Abstract:
Notch signaling is becoming the focus of investigation in a large number of laboratories around the world due to its pleiotropic effect in regulating normal development and alterations in cancer. During the last decade, the scientific community studying this pathway has made significant contributions to our understanding of the cellular role of Notch signaling in regulating proliferation, differentiation, apoptosis, migration, branching morphogenesis, and angiogenesis. Similar to observations with other signaling cascades, such as TGBβ, besides its role in morphogenesis, Notch signaling becomes dysregulated in adult tissue and contributes to the development and maintenance of the cancer phenotype. Elegant studies in this field of research have lead to not only the better understanding of the molecules within the pathway, but as a consequence, rational design of drugs that can inhibit Notch signaling with promising results. The study of Notch signaling in the pancreas has dawned on solid ground and thus, we predict that in the next few years, a better understanding of the pathway at the mechanistic level, along with a strict testing of pharmacological antagonists, will advance the field of pancreatic cancer research in a significant manner.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Horowitz A, Simons M: Branching morphogenesis. Circ Res 2008;103:784–795.
Ghosh B, Leach SD: Interactions between hairy/enhancer of split-related proteins and the pancreatic transcription factor Ptf1-p48 modulate function of the PTF1 transcriptional complex. Biochem J 2006;393:679–685.
Leach S: Epithelial differentiation in pancreatic development and neoplasia: new niches for nestin and Notch. J Clin Gastroenterol 2005;39:S78–S82.
Lomberk G, Fernandez-Zapico M, Urrutia R: When developmental signaling pathways go wrong and their impact on pancreatic cancer development. Curr Opin Gastroenterol 2005;21:555–560.
Masui T, Long Q, Beres T, Magnuson M, MacDonald R: Early pancreatic development requires the vertebrate suppressor of hairless (RBPJ) in the PTF1 bHLH complex. Genes Dev 2007;21:2629–2643.
Murtaugh LC, Stanger BZ, Kwan KM, Melton DA: Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA 2003;100:14920–14925.
Nakhai H, Siveke J, Klein B, Mendoza-Torres L, Mazur P, Algul H, Radtke F, Strobl L, Zimber-Strobl U, Schmid R: Conditional ablation of Notch signaling in pancreatic development. Development 2008;135:2757–2765.
McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, Spinner NB: NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the Notch signaling pathway. Am J Hum Gen 2006;79:169–173.
Miele L, Golde T, Osborne B: Notch signaling in cancer. Curr Mol Med 2006;6:905–918.
Miele L, Miao H, Nickoloff BJ: NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets 2006;6:313–323.
Talora C, Campese AF, Bellavia D, Felli MP, Vacca A, Gulino A, Screpanti I: Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes. Biochim Biophys Acta 2008;1782:489–497.
Turnpenny P, Alman B, Cornier A, Giampietro P, Offiah A, Tassy O, Pourquié O, Kusumi K, Dunwoodie S: Abnormal vertebral segmentation and the notch signaling pathway in man. Dev Dyn 2007;236:1456–1474.
Warthen D, Moore E, Kamath B, Morrissette J, Sanchez P, Piccoli D, Krantz I, Spinner N: Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat 2006;27:436–443.
Watt FM, Estrach S, Ambler CA: Epidermal Notch signalling: differentiation, cancer and adhesion. Curr Opin Cell Biol 2008;20:171–179.
Siveke T, ÄìMartellato CL, Lee M, Mazur P, Nakhai H, Radtke F, Schmid R: Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology 2008;134:544–555.
De La O J-P, Emerson LL, Goodman JL, Froebe SC, Illum BE, Curtis AB, Murtaugh LC: Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci USA 2008;105:18907–18912.
Fleming RJ: Structural conservation of Notch receptors and ligands. Semin Cell Dev Biol 1998;9:599–607.
Lomberk G, Urrutia R: Primers on molecular pathways – notch. Pancreatology 2008;8:103–104.
Wilson A, Radtke F: Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 2006;580:2860–2868.
D'Souza B, Miyamoto A, Weinmaster G: The many facets of Notch ligands. Oncogene 2008;27:5148–5167.
LaVoie MJ, Selkoe DJ: The Notch ligands, jagged and delta, are sequentially processed by {alpha}-secretase and presenilin/{gamma}-secretase and release signaling fragments. J Biol Chem 2003;278:34427–34437.
Gonczy P: Mechanisms of asymmetric cell division: flies and worms pave the way. Nat Rev Mol Cell Biol 2008;9:355–366.
Gordon WR, Arnett KL, Blacklow SC: The molecular logic of Notch signaling – a structural and biochemical perspective. J Cell Sci 2008;121:3109–3119.
Parks AL, Stout JR, Shepard SB, Klueg KM, Dos Santos AA, Parody TR, Vaskova M, Muskavitch MAT: Structure-function analysis of delta trafficking, receptor binding and signaling in drosophila. Genetics 2006;174:1947–1961.
Shimizu K, Chiba S, Kumano K, Hosoya N, Takahashi T, Kanda Y, Hamada Y, Yazaki Y, Hirai H: Mouse jagged1 physically interacts with Notch2 and other Notch receptors. Assessment by quantitative methods. J Biol Chem 1999;274:32961–32969.
Fiuza U-M, Arias AM: Cell and molecular biology of Notch. J Endocrinol 2007;194:459–474.
Pintar A, De Biasio A, Popovic M, Ivanova N, Pongor S: The intracellular region of Notch ligands: does the tail make the difference? Biol Direct 2007;2:19.
Wheeler SR, Stagg SB, Crews ST: Multiple Notch signaling events control drosophila CNS midline neurogenesis, gliogenesis and neuronal identity. Development 2008;135:3071–3079.
Nichols J, Miyamoto A, Weinmaster G: Notch signaling: constantly on the move. Traffic 2007;8:959–969.
Nichols JT, Miyamoto A, Olsen SL, D'Souza B, Yao C, Weinmaster G: DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J Cell Biol 2007;176:445–458.
Steiner H, Fluhrer R, Haass C: Intramembrane proteolysis by {gamma}-secretase. J Biol Chem 2008;283:29627–29631.
Six E, Ndiaye D, Laabi Y, Brou C, Gupta-Rossi N, Israel A, Logeat F: The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc Natl Acad Sci USA 2003;100:7638–7643.
Borggrefe T, Oswald F: The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 2009. Epub ahead of print.
McElhinny AS, Li JL, Wu L: Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene 2008;27:5138–5147.
Fischer A, Gessler M: Delta Notch and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucl Acids Res 2007;35:4583–4596.
Esni F, Ghosh B, Biankin AV, Lin JW, Albert MA, Yu X, MacDonald RJ, Civin CI, Real FX, Pack MA, Ball DW, Leach SD: Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 2004;131:4213–4224.
Kimura K, Satoh K, Kanno A, Hamada S, Hirota M, Endoh M, Masamune A, Shimosegawa T: Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Sci 2007;98:155–162.
Guo X, Wang X-F: Signaling cross-talk between TGF-[beta]/BMP and other pathways. Cell Res 2009;19:71–88.
Holderfield MT, Hughes CCW: Crosstalk between vascular endothelial growth factor, Notch, and transforming growth factor-{beta} in vascular morphogenesis. Circ Res 2008;102:637–652.
Krejcí A, Bernard F, Housden B, Collins S, Bray S: Direct response to Notch activation: signaling crosstalk and incoherent logic. Sci Signal 2009;2:ra1.
Shih I-M, Wang T-L: Notch signaling, {gamma}-secretase inhibitors, and cancer therapy. Cancer Res 2007;67:1879–1882.
Limbourg FP, Takeshita K, Radtke F, Bronson RT, Chin MT, Liao JK: Essential role of endothelial Notch1 in angiogenesis. Circulation 2005;111:1826–1832.
Doi H, Iso T, Sato H, Yamazaki M, Matsui H, Tanaka T, Manabe I, Arai M, Nagai R, Kurabayashi M: Jagged1-selective Notch signaling induces smooth muscle differentiation via a rbp-j{kappa}-dependent pathway. J Biol Chem 2006;281:28555–28564.
Dufraine J, Funahashi Y, Kitajewski J: Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008;27:5132–5137.
Gridley T: Notch signaling in vascular development and physiology. Development 2007;134:2709–2718.
Trindade A, Ram Kumar S, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A: Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood 2008;112:1720–1729.
MacKenzie F, Duriez P, Larrivee B, Chang L, Pollet I, Wong F, Yip C, Karsan A: Notch4-induced inhibition of endothelial sprouting requires the ankyrin repeats and involves signaling through RBP-J{kappa}. Blood 2004;104:1760–1768.
Truty M, Urrutia R: Basics of TGF-beta and pancreatic cancer. Pancreatology 2007;7:423–435.
Armulik A, Abramsson A, Betsholtz C: Endothelial/pericyte interactions. Circ Res 2005;97:512–523.
Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, Lendahl U, Ibanez CF: Cross-talk between the Notch and TGF-{beta} signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 2003;163:723–728.
Niimi H, Pardali K, Vanlandewijck M, Heldin C-H, Moustakas A: Notch signaling is necessary for epithelial growth arrest by TGF-{beta}. J Cell Biol 2007;176:695–707.
Itoh F, Itoh S, Goumans M, Valdimarsdottir G, Iso T, Dotto G, Hamamori Y, Kedes L, Kato M, ten Dijke P: Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J 2004;23:541–551.
Thurston G, Kitajewski J: VEGF and delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer 2008;99:1204–1209.
Siekmann AF, Lawson ND: Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007;445:781–784.
Banerjee S, Mehta S, Haque I, Sengupta K, Dhar K, Kambhampati S, Van Veldhuizen PJ, Banerjee SK: VEGF-A165 induces human aortic smooth muscle cell migration by activating Neuropilin-1-VEGFR1-PI3K Axis†. Biochemistry 2008;47:3345–3351.
Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD,.Wiegand SJ: Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 2007;104:3219–3224.
Jiang Z, Song J, Qi F, Xiao A, An X, Liu N-a, Zhu Z, Zhang B, Lin S: exdpf is a key regulator of exocrine pancreas development controlled by retinoic acid and ptf1a in Zebrafish. PLoS Biol 2008;6:e293.
Bernardo AS, Hay CW, Docherty K: Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic [beta] cell. Mol Cell Endocrinol 2008;294:1–9.
Fukuda A, Kawaguchi Y, Furuyama K, Kodama S, Horiguchi M, Kuhara T, Kawaguchi M, Terao M, Doi R, Wright CVE, Hoshino M, Chiba T, Uemoto S: Reduction of Ptf1a gene dosage causes pancreatic hypoplasia and diabetes in mice. Diabetes 2008;57:2421–2431.
Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, de Angelis MH, Lendahl U, Edlund H: Notch signalling controls pancreatic cell differentiation. Nature 1999;400:877–881.
Pear W, Aster J: T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 2004;11:426–433.
Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM, Leach SD: Notch mediates TGF[alpha]-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003;3:565–576.
Wagner M, Greten F, Weber C, Koschnick S, 1 Torsten Mattfeldt T, Deppert W, Kern H, Adler G, Roland M, Schmid R: A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 2001;15(3):286–293.
Büchler P, Gazdhar A, Schubert M, Giese N, Reber H, Hines O, Giese T, Ceyhan G, Müller M, Büchler M, Friess H: The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg 2005;242:791–800.
Doucas H, Mann C, Sutton C, Garcea G, Neal C, Berry D, Manson M: Expression of nuclear notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol 2008;97:63–68.
Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH: Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006;5:483–493.
Wolfe M: Gamma-secretase modulators. Curr Alzheimer Res 2007;4:571–573.
Imbimbo B: Therapeutic potential of γ-secretase inhibitors and modulators. Curr Top Med Chem 2008;8:54–61.
Acknowledgments
Work in the author’s laboratory (R.U.) is supported by funding from the National Institutes of Health DK 52913 and Mayo Clinic Pancreatic SPORE (P50 CA102701).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this entry
Cite this entry
Lomberk, G., Urrutia, R. (2010). Notch Signaling in Pancreatic Morphogenesis and Pancreatic Cancer Pathogenesis. In: Pancreatic Cancer. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77498-5_18
Download citation
DOI: https://doi.org/10.1007/978-0-387-77498-5_18
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77497-8
Online ISBN: 978-0-387-77498-5
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences